Dawah Pharmaceuticals, Inc. — Form D

Dawah Pharmaceuticals, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-15. The offering totals $10.0M, of which $580K was reported sold. Industry: Manufacturing.

Offering

• Filed: 2019-10-15
• Form: D
• Accession: 0001738106-19-000003
• Industry: Manufacturing
• Exemptions: 06c
• Total offering: $10.0M
• Amount sold: $580K
• Remaining: $9.4M
• Minimum investment: $25K
• Investors: 6
• Date of first sale: 2018-03-19
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-351062

Issuer

• Name: Dawah Pharmaceuticals, Inc.
• CIK: 0001738106
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 251 LITTLE FALLS DRIVE, WILMINGTON, DE, 19808
• Phone: 516-418-8058

Officers, directors & promoters (1)

More

• CIK 1738106 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search